Present and future of lung cancer vaccines

Luis E Raez1, Joseph D Rosenblatt, Eckhard R Podack

  • 1Thoracic Oncology Group, Sylvester Comprehensive Cancer Center, Division of Hematology-Oncology, University of Miami School of Medicine, 1475 NW 12 Avenue, Miami, FL 33136, USA. LRaez@med.miami.edu

Insights

Lung cancer vaccines are an emerging immunotherapy approach. Early trials show promising immune responses and potential clinical activity, offering new avenues for lung cancer treatment.

Area of Science:

  • Oncology
  • Immunology
  • Vaccine Development

Background:

  • Lung cancer treatment requires novel approaches.
  • Vaccine therapy to induce immune responses against lung tumor cells is a promising strategy.
  • Lung tumors have historically been challenging targets for immunotherapy.

Purpose of the Study:

  • To review recent developments in lung cancer vaccines.
  • To highlight the potential of immunotherapy in lung cancer treatment.
  • To discuss the identification of tumor-specific antigens for improved vaccine efficacy.

Main Methods:

  • Review of preclinical and clinical trials of lung cancer vaccines.
  • Analysis of immune response induction in patients.
  • Evaluation of preliminary clinical activity data.

Main Results:

  • Preclinical trials suggest immunotherapy has activity in lung cancer.
  • Clinical trials demonstrate the induction of immune responses.
  • Preliminary data indicate potential clinical activity of lung cancer vaccines.

Conclusions:

  • Lung cancer vaccines represent an attractive therapeutic strategy.
  • Further research into tumor antigens and immune mechanisms is crucial.
  • Vaccine-based immunotherapy holds promise for future lung cancer therapy.

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.